• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺病学领域的个性化分析]

[Personalized profiling in the field of senology].

作者信息

Behrens Annika S, Beckmann Matthias W, Fasching Peter A, Huebner Hanna, Emons Julius

机构信息

Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstraße 21-23, 91054, Erlangen, Deutschland.

出版信息

Radiologie (Heidelb). 2025 Mar;65(3):194-200. doi: 10.1007/s00117-024-01410-0. Epub 2025 Jan 22.

DOI:10.1007/s00117-024-01410-0
PMID:39843711
Abstract

BACKGROUND

The concept of personalized medicine is becoming increasingly important. The possibilities of diagnostics include not only genetic and molecular tumor profiles, but also the use of precise and individual imaging techniques.

OBJECTIVES

The development and implementation of suitable diagnostic procedures with high sensitivity and specificity, which are at the same time tailored to the individual risk factors and biological characteristics of the patient, remain a challenge.

MATERIALS AND METHODS

To enable personalized profiling, comprehensive diagnostics must be established that take into account all parameters such as imaging, molecular and genetic markers as well as real-world data and the use of artificial intelligence. This article sheds light on different approaches to personalized diagnostics in breast cancer and highlights the current clinical standard, innovative areas of research and the resulting challenges.

CONCLUSION

The highest hurdles for newer imaging techniques are the standardization of image analysis and the validation of these techniques in large clinical trials. The use of artificial intelligence requires not only appropriate technical and medical expertise, but also a sensitive approach to issues such as data protection and patient privacy. Real-world registries offer insights into real world treatment situations and are therefore of great importance.

摘要

背景

个性化医疗的概念正变得越来越重要。诊断的可能性不仅包括基因和分子肿瘤图谱,还包括使用精确的个体化成像技术。

目的

开发并实施具有高灵敏度和特异性、同时又能根据患者个体风险因素和生物学特征量身定制的合适诊断程序,仍然是一项挑战。

材料与方法

为实现个性化分析,必须建立综合诊断方法,将成像、分子和基因标志物以及真实世界数据和人工智能的应用等所有参数都考虑在内。本文阐述了乳腺癌个性化诊断的不同方法,并突出了当前的临床标准、创新研究领域以及由此产生的挑战。

结论

更新的成像技术面临的最大障碍是图像分析的标准化以及这些技术在大型临床试验中的验证。人工智能的使用不仅需要适当的技术和医学专业知识,还需要对数据保护和患者隐私等问题采取敏感的处理方式。真实世界登记处提供了对真实世界治疗情况的洞察,因此非常重要。

相似文献

1
[Personalized profiling in the field of senology].[乳腺病学领域的个性化分析]
Radiologie (Heidelb). 2025 Mar;65(3):194-200. doi: 10.1007/s00117-024-01410-0. Epub 2025 Jan 22.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Sexual Harassment and Prevention Training性骚扰与预防培训
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Short-Term Memory Impairment短期记忆障碍
8
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.影响重症成人和儿童机械通气撤机方案使用的因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2.
9
Systemic Inflammatory Response Syndrome全身炎症反应综合征
10
Advancements in AI based healthcare techniques with FOCUS ON diagnostic techniques.人工智能在医疗保健领域的进展,重点关注诊断技术。
Comput Biol Med. 2024 Sep;179:108917. doi: 10.1016/j.compbiomed.2024.108917. Epub 2024 Jul 25.

本文引用的文献

1
Evaluation of ChatGPT's Potential in Tailoring Gynecological Cancer Therapies.评估 ChatGPT 在定制妇科癌症疗法方面的潜力。
In Vivo. 2024 Jul-Aug;38(4):1649-1659. doi: 10.21873/invivo.13614.
2
Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.关于在临床实践中使用 CanRisk 的联合 ABS-UKCGG-CanGene-CanVar 共识。
Br J Cancer. 2024 Jun;130(12):2027-2036. doi: 10.1038/s41416-024-02733-4. Epub 2024 Jun 4.
3
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
早期乳腺癌患者肿瘤中RANK和RANKL的表达
Geburtshilfe Frauenheilkd. 2023 Nov 22;84(1):77-85. doi: 10.1055/a-2192-2998. eCollection 2024 Jan.
4
Predicting mammographic density with linear ultrasound transducers.用线性超声换能器预测乳腺密度。
Eur J Med Res. 2023 Sep 28;28(1):384. doi: 10.1186/s40001-023-01327-9.
5
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.人工智能支持的屏幕阅读与人工智能筛查中的标准双读(MASAI)试验:一项随机、对照、非劣效、单盲、筛查准确性研究的临床安全性分析。
Lancet Oncol. 2023 Aug;24(8):936-944. doi: 10.1016/S1470-2045(23)00298-X.
6
Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer.人工智能系统和容积密度对间期、筛查和进展期乳腺癌风险预测的影响。
J Clin Oncol. 2023 Jun 10;41(17):3172-3183. doi: 10.1200/JCO.22.01153. Epub 2023 Apr 27.
7
Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows.评估用于提取循环无细胞 DNA 的自动化技术,以在标准化高通量工作流程中实施。
Sci Rep. 2023 Jan 7;13(1):373. doi: 10.1038/s41598-022-27216-5.
8
PADA-1 trial: ESR1 mutations in plasma ctDNA guide treatment switching.PADA-1试验:血浆循环肿瘤DNA中的ESR1突变指导治疗方案转换。
Nat Rev Clin Oncol. 2023 Feb;20(2):67-68. doi: 10.1038/s41571-022-00712-3.
9
Return of individual genomic research results within the PRAEGNANT multicenter registry study.个体基因组研究结果在 PRAEGNANT 多中心注册研究中的回报。
Breast Cancer Res Treat. 2023 Jan;197(2):355-368. doi: 10.1007/s10549-022-06795-x. Epub 2022 Nov 21.
10
[Multimodal, multiparametric and genetic breast imaging].[多模态、多参数及基因乳腺成像]
Radiologe. 2021 Feb;61(2):183-191. doi: 10.1007/s00117-020-00801-3. Epub 2021 Jan 19.